Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com

Letter for COVID-19 treatments

Published:: April 2023
Content type:: Publication

Myeloma UK Letter for COVID-19 treatments

PDF / 163KB Download

This letter is for myeloma patients experiencing difficulties explaining eligibility for COVID-19 treatments to a healthcare professional. Download this letter to give to your GP and/or healthcare team to inform them about your eligibility to receive COVID-19 treatments.

Stay in touch

We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.

Sign up

Accreditation and memberships

The Association of Medical Research Charities (AMRC) is dedicated to helping medical research charities save and improve lives through research and innovation.

The Helplines Standard is the nationally recognised quality standard which defines and certifies best practice in helpline work.

The Patient Information Forum’s Trusted Information Creator is Europe’s only assessed quality mark for online and printed health information.

The Scottish Fundraising Adjudication Panel is responsible for fundraising standards in Scotland and handles any fundraising complaints related to Scottish registered charities.

EViR is an international community of research funders, those who represent research funders and those who set research funding policy.

Letter for COVID-19 treatments

Myeloma UK Letter for COVID-19 treatments

Browse library content

Stay in touch

Accreditation and memberships